Trials / Completed
CompletedNCT03467971
A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants
A Randomized, Open-label, Single Dose, 2x2 Crossover Trial to Evaluate the Food Effect on the Bioavailability of a Metformin/Gliclazide Fixed Combination Tablet (1000 mg /30 mg MR) Given in Fasting and Fed Conditions to Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the food effect on bioavailability of Metformin/Gliclazide fixed dose combination tablet in fed and fasted state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin/Gliclazide Fixed Combination | Participants will receive single oral dose of Metformin 1000 mg and Gliclazide 30 mg fixed combination tablet in fasting or fed state. |
Timeline
- Start date
- 2018-03-06
- Primary completion
- 2018-04-22
- Completion
- 2018-04-22
- First posted
- 2018-03-16
- Last updated
- 2019-07-08
- Results posted
- 2019-07-08
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT03467971. Inclusion in this directory is not an endorsement.